ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

CCCC C4 Therapeutics Inc

6,16
-0,64 (-9,41%)
11 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
C4 Therapeutics Inc CCCC NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,64 -9,41% 6,16 06:00:13
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
6,85 6,15 6,935 6,16 6,80
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.5.202413:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.5.202413:07EDGAR2Form 8-K - Current report
08.5.202413:00GLOBEC4 Therapeutics Reports First Quarter 2024 Financial Results..
29.4.202422:01GLOBEC4 Therapeutics Announces Inducement Grant Under Nasdaq..
09.4.202413:00GLOBEC4 Therapeutics to Participate in the Stifel 2024 Targeted..
08.4.202414:00GLOBEC4 Therapeutics Presents New Preclinical Data for CFT1946..
09.3.202401:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.3.202401:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.3.202401:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.3.202401:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.3.202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:10EDGAR2Form 8-K - Current report
05.3.202422:30GLOBEC4 Therapeutics to Present New Preclinical Data on Highly..
04.3.202413:05EDGAR2Form 8-K - Current report
04.3.202413:00GLOBEC4 Therapeutics Announces Strategic Discovery Research..
22.2.202415:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
22.2.202413:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22.2.202413:15EDGAR2Form 8-K - Current report
22.2.202413:00GLOBEC4 Therapeutics Reports Fourth Quarter and Full Year 2023..
15.2.202423:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202415:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05.2.202416:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02.2.202415:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.1.202422:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11.1.202413:05EDGAR2Form 8-K - Current report
09.1.202422:06EDGAR2Form 8-K - Current report
09.1.202422:01GLOBEC4 Therapeutics Announces 2024 Priorities and Extended Cash..
04.1.202422:01GLOBEC4 Therapeutics Announces Closing of $25 Million Equity..
04.1.202413:00GLOBEC4 Therapeutics to Present at the 42nd Annual J.P. Morgan..
03.1.202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.12.202322:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12.12.202322:28EDGAR2Form 8-K - Current report
12.12.202322:01GLOBEC4 Therapeutics Announces Positive Data from CFT7455 Phase 1..
12.12.202315:15APSBiotech Catches Major Premarket Bid
12.12.202313:15EDGAR2Form 8-K - Current report
12.12.202313:00GLOBEC4 Therapeutics Announces License and Research Collaboration..
28.11.202313:00GLOBEC4 Therapeutics to Host Webcast to Present New Dose..
20.11.202313:05EDGAR2Form 8-K - Current report
20.11.202313:00GLOBEC4 Therapeutics Strengthens Board of Directors with Owen..
13.11.202322:55EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01.11.202312:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.11.202312:18EDGAR2Form 8-K - Current report
01.11.202312:00GLOBEC4 Therapeutics Reports Third Quarter 2023 Financial Results..
11.10.202313:00GLOBEC4 Therapeutics Announces Upcoming Data Presentations for..
03.10.202322:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht